1. SO-006Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers. (2nd July 2019) Authors: Baere, T De; Pracht, M; Rolland, Y; Nguyen, F; Bronowicki, J; Vendrely, V; Cunha, A Sa; Baumann, A; Croisé-Laurent, V; Rio, E; Sourd, S Le; Gustin, P; Perret, C; Peiffert, D; Deutsch, E; Chajon, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. When helping the minority of patients may hurt the majority: The case for DPD phenotyping and 5-fluorouracil therapeutic drug monitoring. Issue 2 (February 2021) Authors: Tron, C; Lemaitre, F; Boisteau, Emeric; Sourd, S Le; Lièvre, A Journal: Digestive and liver disease Issue: Volume 53:Issue 2(2021) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗